Vaccine contents
Mise à jour des recommandations concernant l'utilisation de vaccins contenant du thimérosal au Canada
Conclut qu’il n’y a aucune raison pour les vaccinateurs et les autres professionnels de la santé qui offrent des conseils en matière de vaccination d’exprimer des réserves concernant l’exposition au thimérosal.
Updated recommendations on the use of thimerosal-containing vaccines in Canada
Concludes that there is no reason for vaccine providers or other health care professionals who may counsel individuals regarding immunization to raise any concerns regarding exposure to thimerosal.
Thimerosal exposure in infants and developmental disorders : a prospective cohort study in the United Kingdom does not support a causal association
Describes research that tested a large United Kingdom population-based cohort to find out whether there is any evidence to justify concerns that exposure to mercury damages young children.
Autism and thimerosal-containing vaccines: lack of consistent evidence for an association
Compared the prevalence/incidence of autism in California, Sweden, and Denmark with average exposures to thimerosal-containing vaccines.
Déclaration sur le thimérosal
Fournit des recommandations sur l’utilisation des vaccins homologués au Canada qui contiennent du thimérosal, un agent de conservation à base de mercure.
Statement on thimerosal
Provide recommendations on the use of vaccines licensed for use in Canada that contain the mercury-based preservative thimerosal.
Thimerosal and the occurrence of autism : negative ecological evidence from Danish population-based data
Examines whether discontinuing the use of thimerosal-containing vaccines in Denmark led to a decrease in the incidence of autism.
Exposition au thimérosal contenu dans les vaccins administrés dans le cadre des programmes de vaccination infantile au Canada et risques d'anomalies du développement neurologique
Examine le risque d’anomalies du développement neurologique, y compris l’autisme, chez les nourrissons/enfants au Canada résultant de l’exposition au mercure dans des vaccins contenant le thimérosal dans des programmes provinciaux/territoriaux actuels de vaccination des nourrissons et des petits enfants.
Exposure to thimerosal in vaccines used in Canadian infant immunization programs, with respect to risk of neurodevelopmental disorders
Examines the risk of neurodevelopmental disorders, including autism, in Canadian children as a result of mercury exposure from thimerosal-containing vaccines routinely used in some provincial/territorial universal infant and early childhood immunization programs